SCHEMBL5095145

SCHEMBL5095145

CCCCCCC#CC=CC#Cc1ccccc1C(=O)O

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HMGCR P04035 2/20 0.44
CYSLTR2 Q9NS75 1/20 0.44
CYSLTR1 Q9Y271 1/20 0.44
FFAR1 O14842 1/20 0.42
FFAR4 Q5NUL3 1/20 0.42
MMP2 P08253 1/20 0.41
MMP12 P39900 1/20 0.41
CA12 O43570 2/20 0.40
CA9 Q16790 2/20 0.40
CYP3A4 P08684 4/20 0.40
TSHR P16473 1/20 0.40
ALDH1A1 P00352 2/20 0.40
CYP2C9 P11712 2/20 0.39
CYP2C19 P33261 2/20 0.39
KDM4E B2RXH2 2/20 0.39
MAPT P10636 2/20 0.39
HSD17B10 Q99714 2/20 0.39
TDP1 Q9NUW8 2/20 0.39
LMNA P02545 1/20 0.39
CYP1A2 P05177 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5095139 1.00 HMGCR (0.44) HMGCRCYSLTR2CYSLTR1FFAR1FFAR4
SCHEMBL4790549 0.85 CYSLTR2 (0.53) CYSLTR2CYSLTR1FFAR1FFAR4MMP2
SCHEMBL19331451 0.81 KDM4E (0.56) CYSLTR2CYSLTR1FFAR1FFAR4CA12
SCHEMBL5092715 0.77 CYP3A4 (0.38) HMGCRCYSLTR2CYSLTR1FFAR1FFAR4
SCHEMBL5092707 0.77 CYP3A4 (0.38) HMGCRCYSLTR2CYSLTR1FFAR1FFAR4
SCHEMBL5089552 0.75 CYP3A4 (0.40) HMGCRCYSLTR2CYSLTR1FFAR1FFAR4
SCHEMBL5089556 0.75 CYP3A4 (0.40) HMGCRCYSLTR2CYSLTR1FFAR1FFAR4
SCHEMBL29087832 0.75 CYSLTR2 (0.52) CYSLTR2CYSLTR1FFAR1FFAR4MMP2
SCHEMBL10810743 0.74 KDM4E (0.45) CYSLTR2CYSLTR1FFAR1CA12CA9
SCHEMBL31317036 0.74 CYP3A4 (0.51) CYSLTR2CYSLTR1FFAR1FFAR4MMP2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7332623-B2 Aryl-substituted acyclic enediyne compounds KAOHSIUNG MEDICAL UNIVERSITY (TW) 2008-02-19 US disclosed
US-20050004212-A1 Aryl-substituted acyclic enediyne compounds KAOHSIUNG MEDICAL UNIVERSITY 2005-01-06 US disclosed
US-20050004211-A1 Pharmaceutical compositions comprising aryl-substituted acyclic enediyne compounds KAOHSIUNG MEDICAL UNIVERSITY 2005-01-06 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20050004211-A1 Pharmaceutical compositions comprising aryl-substituted acyclic enediyne compounds CCNI, TOP1, TOP2B HMGCR 1395/4885CYSLTR2 3502/4885CYSLTR1 2827/4885
US-20050004212-A1 Aryl-substituted acyclic enediyne compounds CCNI, TOP2B, TOP2A HMGCR 2769/4885CYSLTR2 4039/4885CYSLTR1 3586/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.